Background: Pre-labour rupture of membranes (PROM) at term is a common event with early induction of labour reducing infectious morbidity without increasing the caesarean rate. Syntocinon is commonly used for induction but prostaglandins are also routinely used. Large studies have shown no difference in the maternal and neonatal outcomes with either method.
gible. Women with a previous caesarean section, where there was an indication for immediate delivery, where there was suspected or confirmed chorioamnionitis or if they were known to have Group B Streptococcus colonisation, were excluded from the study.
Women were randomised to induction with oxytocin or with PG gel using a computer-generated list of random numbers created by a member not involved in clinical care or assessment of pregnancy outcome. Allocation to one or the other group was by opening serially numbered sealed opaque envelopes kept in the birth suite. After obtaining informed consent the admitting clinician recorded the name and hospital identification number of the participant in the research register and opened the next consecutively numbered envelope containing the allocation. After randomisation the participant remained in that group irrespective of the actual method used for the induction (intention to treat analysis). For the oxytocin group, oxytocin infusion was initiated as soon as it was feasible depending on the workload in the birth suite. For women in the PG group, PGE2 gel was inserted into the posterior fornix according to our regime (initial dose of 2 mg for primigravida and 1 mg for multigravida; thereafter the repeat dose was 2 mg six-hourly).
If there was no evidence of onset of labour six hours after the third dose of PGE2, oxytocin infusion was commenced. Labour in both groups was managed according to the standard birth suite protocol for the Unit. Outcome data were obtained by a member of the research team by reviewing the medical records following discharge. Participants were requested to complete a postnatal survey prior to going home or on day three by phone if discharged early.
To demonstrate that 50% of women in the PG group begin labour without needing oxytocin, and that the epidural rate drops from 30 to 20%, we would need a sample size of 133 women in each group with 95% confidence and 80% power.
To achieve 80% power to demonstrate non-inferiority with the incidence of neonatal sepsis of 5% we would need a much larger sample size of over 3000 women. This was not thought to be feasible.
Data management was undertaken using Excel. Analysis examined baseline characteristics of all randomised women, as an indication of comparable treatment groups. Outcome comparisons were made on an intention to treat basis. The relative risks and 95% confidence intervals are reported for the major outcomes.
RESULTS
During the study period one of the investigators moved hospital and there was lack of research support, resulting in the inability to achieve the desired sample size. A total of 184 women were recruited, 90 in the PG group and 94 in the oxytocin group, as shown in the consort flow chart in Figure 1 . Table 1 No agent required n (%) 3 (3.3) 9 (9.6)
Outcome data is shown in Table 2 . More than half of women (53%) in the PG group did not require any oxytocin. This was particularly so in multiparous women in whom 67% did not need oxytocin. Overall there was a lower incidence of fetal heart rate (FHR) abnormality requiring intervention in the PG group, 4.4% versus 12.8% in the oxytocin group. This was statistically significant in the nulliparous women, 2% versus 18.5%, respectively, relative risk (RR) 9.25; 95%CI 1.23-69.8.
There was no difference between the groups in terms of the need for epidural or caesarean section, irrespective of parity.
In terms of infection risk there was no difference between the groups in terms of maternal infection, admission to the special care nursery or neonatal sepsis (proven or suspected). However, the numbers are insufficient to say that no difference exists.
The time between PROM and the onset of labour was significantly longer in the PG group (25.7 h in the PG group and 19.7 h in the oxytocin group). However, there was no difference between the groups in the length of the first stage of labour.
The results of the maternal satisfaction questionnaire are shown in Table 3 . The feedback was strongly positive in both groups. The oxytocin group reported greater satisfaction with the method used to start their labour (83% with oxytocin vs 69% with PG, P = 0.002), labour pains starting as they would have liked (71% with oxytocin vs 57% with PG, P = 0.004) and the time it took to start labour (70% with oxytocin vs 44% with PG, P = 0.001). The higher levels of dissatisfaction in the PG group came from women who had PG and then also required oxytocin.
79.5% of women not needing augmentation with oxytocin were happy with the method used to start this labour. This dropped to 40.5% for women who did need augmentation. Women in the oxytocin group did report a higher incidence of side effects 
DISCUSSION
This study has shown that significantly more women in the PG group went into labour without the need for oxytocin induction or augmentation. Induction with PG may be a reasonable option for women who might perceive PG gel as less intervention than an oxytocin infusion. The PG group in our study did have a significantly lower rate of intervention for foetal heart rate abnormalities. There was no difference in caesarean section rates between the two groups as has been noted in other studies.
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Our epidural rate was similarly high in both groups, around 40% overall and nearly 60% for nulliparous women. This may reflect the current trend toward better pain relief in labour. Previous publications noted in a review paper 11 reported that women having labour induced with PGs were less likely to need epidural analgesia. This suggests that women induced with oxytocin may find labour more painful (possibly because of quicker onset of contractions) and thus more difficult to handle than if labour was induced with PGs.
We did not see any significant difference between the groups in terms of maternal infection, neonatal infection (suspected or proven) or admission to the special care nursery, although a non-significant increase was seen in nulliparous women in the oxytocin group. The large TERM PROM study The lack of infective complications in the PG group could be due to the fact that we had specifically excluded women who were GBS positive (10% were GBS positive in the TERM PROM study 3 and among women colonised with group B Streptococcus, the rates of neonatal infection was 2.5% in the oxytocin vs over 8% in the PG group) . It may be that our sample size was just too small to show any effect. However, two meta-analyses 11, 12 have also concluded that induction of labour with PGs did not significantly increase or decrease the rate of endometritis and probably also neonatal infection compared to induction of labour with oxytocin.
From a practical point of view, use of oxytocin does increase the demand for closer monitoring and thus added midwifery time, although the cost of caring for women and their babies in the TERM PROM study was less if labour was induced with oxytocin than with PGs. 13 In terms of mode of birth we also did not note any significant difference between the groups regarding the caesarean section rate.
What were the women's experiences? It appears that women preferred oxytocin induction, possibly due to the shorter time interval to birth. This is despite the fact that many more women in the oxytocin group experienced side effects with its use.
In conclusion, we can confirm that induction of labour with oxytocin or with vaginal PG gel are both reasonable options for women and their babies in the context of PROM at term. Many women in the PG group, particularly the multiparous women, went into labour and did not need oxytocin augmentation and there was no increased risk of maternal or neonatal sepsis.
Women who wish to have active management should therefore be given unbiased information regarding benefits and risks of the two options. Some will choose to have labour induced with oxytocin as it is much quicker, while others, who may wish less intervention and to reduce the risks of needing an intravenous infusion, may prefer to have labour induced with PGs.
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